Study on immune status alterations in patients with sepsis

Area of Science:

• Immunology
• Critical Care Medicine
• Pathophysiology

Background:

• Sepsis presents a complex immune dysregulation characterized by hyper-inflammation and suppressed immune function.
• This immune imbalance significantly contributes to high mortality rates in Intensive Care Units (ICUs).
• Understanding the dynamics of immune and inflammatory biomarkers is crucial for predicting patient outcomes.

Purpose of the Study:

• To investigate dynamic changes in immune and inflammatory responses during sepsis.
• To explore the interactions between immune biomarkers and their association with patient survival.
• To elucidate the temporal patterns of immune cell subsets and cytokine levels in sepsis.

Main Methods:

• Flow cytometry was used to analyze cytokine and lymphocyte subset levels in sepsis patients and healthy donors.
• Data were collected at multiple time points: ICU admission (D0), D3, D7, D14, and D28.
• Statistical analyses included independent sample t-tests and principal component analysis to compare patient groups (survivors vs. non-survivors).

Main Results:

• Sepsis patients exhibited reduced absolute lymphocyte counts and altered lymphocyte subset proportions.
• An increase in regulatory T-cells (Tregs) correlated with disease progression and immunosuppression.
• Factors like age, steroid use, secondary infection, and septic shock were associated with mortality.

Conclusions:

• Sepsis leads to a downregulation of adaptive immunity and prolonged immune suppression.
• Cellular immunity showed signs of recovery within two weeks, but humoral and innate immunity recovery was delayed.
• These findings highlight potential therapeutic targets to modulate immune responses in sepsis patients.